Patricia Lugar, MD, MS, Duke Health
Articles by Patricia Lugar, MD, MS, Duke Health

Unmet Needs in SM Treatment
ByDaniel J. DeAngelo, MD, PhD,Prithviraj Bose, MD,Patricia Lugar, MD, MS, Duke Health,Sa Wang, MD, MD Anderson Cancer Center The panel of experts in SM highlight the unmet needs in the clinical care of systemic mastocytosis.

Case 3: Indolent Systemic Mastocytosis
ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute,Patricia Lugar, MD, MS, Duke Health,Prithviraj Bose, MD, MD Anderson Cancer Center Dan DeAngelo, MD, PhD, presents the case of a patient with indolent systemic mastocytosis and urticaria pigmentosa.

Avapritinib: Approval and Clinical Practice Implications
ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute,Prithviraj Bose, MD, MD Anderson Cancer Center,Patricia Lugar, MD, MS, Duke Health A panel of experts share their reactions to the approval of avapritinib and discuss the clinical implications.

Patricia Lugar, MD, MS, shares an allergist’s perspective regarding treatment algorithms and supportive care recommendations for patients with systemic mastocytosis.

Case 1: Treatment Algorithm and Supportive Care Recommendations
ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute,Sa Wang, MD, MD Anderson Cancer Center,Prithviraj Bose, MD, MD Anderson Cancer Center,Patricia Lugar, MD, MS, Duke Health Patricia Lugar, MD, MS, shares treatment algorithm and supportive care recommendations for a 75-year-old man with systemic mastocytosis.

Case 1: Treatment and Management Considerations
ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute,Sa Wang, MD, MD Anderson Cancer Center,Prithviraj Bose, MD, MD Anderson Cancer Center,Patricia Lugar, MD, MS, Duke Health The panel of experts in SM discuss the diagnosis and management of a 75-year-old man with systemic mastocytosis.

Case 1: 75-Year-Old Man With SM
ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute,Sa Wang, MD, MD Anderson Cancer Center,Prithviraj Bose, MD, MD Anderson Cancer Center,Patricia Lugar, MD, MS, Duke Health Dan DeAngelo, MD, PhD, presents the case of a 75-year-old man with systemic mastocytosis and reviews WHO diagnostic criteria.

Considerations in SM: Hereditary Alpha Tryptasemia
ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute,Sa Wang, MD, MD Anderson Cancer Center,Prithviraj Bose, MD, MD Anderson Cancer Center,Patricia Lugar, MD, MS, Duke Health Prithviraj Bose, MD, and Patricia Lugar, MD, MS, discuss the considerations and testing options for hereditary alpha tryptasemia in patients with systemic mastocytosis.

Considerations in Mast Cell Disorders
ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute,Sa Wang, MD, MD Anderson Cancer Center,Prithviraj Bose, MD, MD Anderson Cancer Center,Patricia Lugar, MD, MS, Duke Health The panel of experts highlights the importance of assessing symptomology and clinical characteristics in mast cell disorders.

Systemic Mastocytosis: Epidemiology and Diagnostic Criteria
ByDaniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute,Sa Wang, MD, MD Anderson Cancer Center,Prithviraj Bose, MD, MD Anderson Cancer Center,Patricia Lugar, MD, MS, Duke Health Experts in the field of mast cell disorders discuss the epidemiology and diagnostic criteria of systemic mastocytosis.